Skip to content

"'Effect of Diabetosit herbal supplement in treatment of Diabetes"

The effect of diabetosit supplement (extract of nettle leaf and olive leaf) on blood glucose and lipid profile in type 2 diabetic patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190728044350N1
Enrollment
30
Registered
2019-09-08
Start date
2019-10-07
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Receiving herbal supplement Diabetosit made by Yasin Teb Gostar Co for 8 weeks, 20 cc, three times a day before meals. Ingredients of 1 Liter Diabet

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: Over 30 years old Under treatment with oral glucose-lowering drugs

Exclusion criteria

Exclusion criteria: Insulin dependent patients History of heart disease or myocardial infarction History of asthma and allergy to nettle Hepatic insufficiency Pregnancy or lactation Thyroid diseases Severe infection Renal Insufficiency

Design outcomes

Primary

MeasureTime frame
Percentage of patients with Fasting blood sugar lower than 140 mg/dl. Timepoint: At baseline and 8 weeks after study. Method of measurement: Biochemical tests are carried out by the Selectra autoanalyser. Total cholesterol will be measured enzymatically using cholesterol esterase and cholesterol oxidase. HDL-C is measured after deposition of lipoproteins containing APO-B by phosphotungstic acid with the same enzymatic method of total cholesterol. Triglycerides will be carried out enzymatically using glycerol phosphate oxidase. LDL-C is measured in serum samples with triglyceride levels equal or less than 400 mg / dl using the Freidwald formula.

Secondary

MeasureTime frame
Blood pressure. Timepoint: At baseline and 8 weeks after. Method of measurement: Using mercury sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Mohtasham-Amiri

Rasht University of Medical Sciences

mohtashamaz@yahoo.com+98 13 3336 8773

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026